Rhesus incompatibility and fetal anaemia
Exam relevance: in 11 of more than 150 board exam reports · rank 64
- Synonyms
- rhesus disease, haemolytic disease of the newborn
- Specialty
- Obstetrics · Pregnancy disorders
- Images
- Histology & cytology 1 · Ultrasound 1
- Exam relevance
- 11 of more than 150 reports · rank 64
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (2)
Histology & cytology
UltrasoundDefinition
- In rhesus incompatibility a Rh(D)-negative pregnant woman carrying a Rh-positive fetus forms antibodies against the D antigen on fetal red cells; in later pregnancies these cross the placenta and cause haemolysis in a Rh-positive fetus.
- The result is haemolytic disease of the fetus and newborn (formerly erythroblastosis fetalis).
Aetiopathogenesis
Aetiology and pathogenesis
- Fetal red cells enter the maternal circulation throughout pregnancy, most at birth or termination of pregnancy; larger fetomaternal haemorrhages occur, for example, after trauma, and the larger the haemorrhage, the more antibodies are formed.
- Other routes of sensitisation are needles contaminated with Rh-positive blood and inadvertent transfusion of Rh-positive blood.
- No complications develop in the sensitising pregnancy; subsequent pregnancies are affected.
- Other blood group systems such as Kell, Duffy, Kidd or Cc and Ee can also cause haemolytic disease; anti-Kell antibodies additionally suppress red cell production in the bone marrow directly.
Clinical features
Clinical features and complications
- In the fetus, haemolysis causes anaemia, hypoalbuminaemia, possibly high-output heart failure and fetal death; immature red cells (erythroblasts) are released into the circulation, and in severe cases hydrops fetalis develops.
- In the neonate, haemolysis raises indirect bilirubin with jaundice up to kernicterus; the pregnant woman herself usually remains asymptomatic.
Diagnosis
- At the first antenatal visit all women are tested for blood group, Rh type and an antibody screen; if relevant antibodies are present, the father's blood group and zygosity and serial titres are determined, with a laboratory-specific critical titre usually between 1:8 and 1:32.
- Fetal Rh status can be determined non-invasively from cell-free fetal DNA in maternal blood (RHD gene).
- An elevated middle cerebral artery flow velocity for gestational age indicates fetal anaemia; fetal haemoglobin is determined by umbilical cord blood sampling.
Treatment principles
- The focus is on prevention through anti-D prophylaxis for rhesus-negative women during pregnancy, after the birth of a rhesus-positive baby and after sensitising events.
- In women already sensitised, antibody levels and Doppler signs of fetal anaemia are monitored in a specialist centre; severe fetal anaemia is treated by intrauterine transfusion.
- The timing of delivery is based on the fetal condition; after birth, neonatology treats anaemia and hyperbilirubinaemia, for example with phototherapy or exchange transfusion.
Specific treatment regimens with drugs and doses are covered in the GynFuchs app.
Keep learning in the app
Further reading (selection)
Cross-references
More topics: Pregnancy disorders
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.
Related pages: Rubella in pregnancy · Thyroid disorders in pregnancy · Selective fetal growth restriction in twins (sFGR)
Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.